Literature DB >> 3111389

Pseudomonas infections in cystic fibrosis.

R H George.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3111389      PMCID： PMC1778407          DOI： 10.1136/adc.62.5.438

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  14 in total

1.  Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Authors:  M E Hodson; A R Penketh; J C Batten
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

Review 2.  Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction.

Authors:  G B Pier
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

3.  Serum IgG antibodies in patients with cystic fibrosis with early Pseudomonas aeruginosa infection.

Authors:  M M Brett; A T Ghoneim; J M Littlewood
Journal:  Arch Dis Child       Date:  1987-04       Impact factor: 3.791

4.  Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patients.

Authors:  J D Klinger; M J Thomassen
Journal:  Diagn Microbiol Infect Dis       Date:  1985-03       Impact factor: 2.803

5.  Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection.

Authors:  M Szaff; N Høiby; E W Flensborg
Journal:  Acta Paediatr Scand       Date:  1983-09

Review 6.  Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology.

Authors:  D A Goldmann; J D Klinger
Journal:  J Pediatr       Date:  1986-05       Impact factor: 4.406

7.  Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains.

Authors:  R S Baltimore; M Mitchell
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

8.  Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis.

Authors:  G Döring; H J Obernesser; K Botzenhart; B Flehmig; N Høiby; A Hofmann
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

9.  Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients.

Authors:  K S Jagger; D L Robinson; M N Franz; R L Warren
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 11.677

10.  Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis.

Authors:  M Granström; A Ericsson; B Strandvik; B Wretlind; O R Pavlovskis; R Berka; M L Vasil
Journal:  Acta Paediatr Scand       Date:  1984-11
View more
  8 in total

1.  Role of energy metabolism in conversion of nonmucoid Pseudomonas aeruginosa to the mucoid phenotype.

Authors:  J M Terry; S E Piña; S J Mattingly
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

2.  Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa.

Authors:  R A Hatch; N L Schiller
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

3.  Control of mucoidy in Pseudomonas aeruginosa: transcriptional regulation of algR and identification of the second regulatory gene, algQ.

Authors:  V Deretic; W M Konyecsni
Journal:  J Bacteriol       Date:  1989-07       Impact factor: 3.490

4.  Evaluation of E-Test for determination of antimicrobial MICs for Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  E F Marley; C Mohla; J M Campos
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

5.  Pseudomonas aeruginosa AlgB, a two-component response regulator of the NtrC family, is required for algD transcription.

Authors:  D J Wozniak; D E Ohman
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

6.  Environmental conditions which influence mucoid conversion Pseudomonas aeruginosa PAO1.

Authors:  J M Terry; S E Piña; S J Mattingly
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

7.  Alginate synthesis in Pseudomonas aeruginosa: the role of AlgL (alginate lyase) and AlgX.

Authors:  S R Monday; N L Schiller
Journal:  J Bacteriol       Date:  1996-02       Impact factor: 3.490

8.  The algR gene, which regulates mucoidy in Pseudomonas aeruginosa, belongs to a class of environmentally responsive genes.

Authors:  V Deretic; R Dikshit; W M Konyecsni; A M Chakrabarty; T K Misra
Journal:  J Bacteriol       Date:  1989-03       Impact factor: 3.490
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.